Very Low-Dose Decitabine is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome. (April 2017)

• Record Type: Journal Article
• Authors: Li, H.; Wang, L.; Wu, Y.; Su, L.; Zhao, H.; Zhang, Y.; Wang, Z.; Huang, D.; Huang, Z.; Wu, X.; Li, X.; Ye, F.; Yu, F.; Liu, H.; Wang, J.; Cong, J.; Sun, W.; Chen, H.; Wang, J.; Han, B.
• Is Part Of: Leukemia research. Volume 55(2017)Supplement 1
• Page Start: S65
• Page End: S66
• Publication Date: 2017-04
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/S0145-2126(17)30218-7
• Languages: English
• ISSNs: 0145-2126